Description
ALINITY M SUPPLIES FOR COVID TESTING
First action · last action
2021-02-11 · 2022-09-22
Transactions
4
First transaction's obligation
$2,085,119
Base + all options value (sum of deltas)
$882,490
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY (FAR 6.302-2)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-02-11+$2,085,119= $2,085,119
- Mod P000012021-04-02+$0= $2,085,119
- Mod P000022021-11-01-$955,606= $1,129,513
- Mod P000032022-09-22-$247,023= $882,490
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-02-11 | +$2,085,119 | $2,085,119 | ALINITY M SUPPLIES FOR COVID TESTING |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2021-04-02 | +$0 | $2,085,119 | ALINITY M SUPPLIES FOR COVID TESTING |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-11-01 | −$955,606 | $1,129,513 | ALINITY M SUPPLIES FOR COVID TESTING |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-09-22 | −$247,023 | $882,490 | ALINITY M SUPPLIES FOR COVID TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NK5QDVJBHMN7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24126N0799 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $658,750 | FY2026 |
| 36C26326P0588 | NETWORK CONTRACT OFFICE 23 (36C263) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $308,299 | FY2026 |
| 36C24126A0041 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24226N0439 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,481,077 | FY2026 |
| 36C24926N0423 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $471,122 | FY2026 |
| 36C24626N0476 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $421,178 | FY2026 |
Other recipients under 6550 from 246-NETWORK CONTRACTING OFFICE 6 (36C246) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24626N0749 | BIOMERIEUX INC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $165,286 | FY2026 |
| 36C24626N0683 | ROCHE DIAGNOSTICS CORPORATION | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $287,950 | FY2026 |
| 36C24626N0663 | CEPHEID | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $160,463 | FY2026 |
| 36C24626N0534 | CEPHEID | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $472,015 | FY2026 |
| 36C24626N0533 | CEPHEID | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $198,013 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24621P0587_3600_-NONE-_-NONE- · retrieved 2026-09-26.